Your browser doesn't support javascript.
loading
Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER.
Jhund, Pardeep S; Kondo, Toru; Butt, Jawad H; Docherty, Kieran F; Claggett, Brian L; Desai, Akshay S; Vaduganathan, Muthiah; Gasparyan, Samvel B; Bengtsson, Olof; Lindholm, Daniel; Petersson, Magnus; Langkilde, Anna Maria; de Boer, Rudolf A; DeMets, David; Hernandez, Adrian F; Inzucchi, Silvio E; Kosiborod, Mikhail N; Køber, Lars; Lam, Carolyn S P; Martinez, Felipe A; Sabatine, Marc S; Shah, Sanjiv J; Solomon, Scott D; McMurray, John J V.
Afiliação
  • Jhund PS; BHF Glasgow Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
  • Kondo T; BHF Glasgow Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
  • Butt JH; BHF Glasgow Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
  • Docherty KF; BHF Glasgow Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
  • Claggett BL; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Desai AS; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Vaduganathan M; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Gasparyan SB; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Bengtsson O; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Lindholm D; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Petersson M; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Langkilde AM; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • de Boer RA; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • DeMets D; University of Wisconsin, Madison, WI, USA.
  • Hernandez AF; Duke University Medical Center, Durham, NC, USA.
  • Inzucchi SE; Yale School of Medicine, New Haven, CT, USA.
  • Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, MO, USA.
  • Køber L; Department of Cardiology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
  • Lam CSP; National Heart Centre Singapore & Duke-National University of Singapore, Singapore, Singapore.
  • Martinez FA; University of Cordoba, Cordoba, Argentina.
  • Sabatine MS; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Shah SJ; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • McMurray JJV; BHF Glasgow Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK. john.mcmurray@glasgow.ac.uk.
Nat Med ; 28(9): 1956-1964, 2022 09.
Article em En | MEDLINE | ID: mdl-36030328
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Cardíaca Tipo de estudo: Systematic_reviews Limite: Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Cardíaca Tipo de estudo: Systematic_reviews Limite: Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos